Multiple pieces of evidence have revealed that FBI-1 is overexpressed in several human cancers, including lung cancer, hepatocellular carcinoma, breast cancer, and colorectal cancer4–7. This evidence concerns the gene ZBTB7A and hepatocellular carcinoma.